NCT06214338

Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

Blood Bioavailability of Two Different Doses of a β-alanine Supplement

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Universidad Católica San Antonio de Murcia · Academic / Other
• Sex: Male
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to To study the blood bioavailability of a sustained-release β-alanine granulated supplement of two different doses (10 g and 20 g).

Detailed description

Subjects will consume 10 g of β-alanine one day by 4 ingestions of 2.5 g separated by 1 hour and 15 min. While on another day 20 g of β-alanine by 4 ingestions of 5 g separated by 1 hour and 15 minutes, with a washout period of 15 days between the two doses. Subsequently, the amino acid levels in blood will be analyzed after the product intake and during a period of 8 hours. Each day of visit the paresthesias (moment of appearance, intensity and sensations) will be studied at different times.

Conditions

• Bioavailability

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Low dose	Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 2.5, separated by 1 hour and 15 min.
DIETARY_SUPPLEMENT	High dose	Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 5 separated by 1 hour and 15 min.

Timeline

• Start date: 2024-02-12
• Primary completion: 2024-03-18
• Completion: 2024-04-15
• First posted: 2024-01-19
• Last updated: 2024-05-20

Locations

1 site across 1 country: Spain